Rhiannon Bath1, Tanner Bucholz, Amy F Buros, Darshan Singh, Kirsten E Smith, Charles A Veltri, Oliver Grundmann. 1. Midwestern University, College of Pharmacy, Department of Pharmaceutical Sciences, Glendale, AZ (RB, TB, CAV, OG); Midwestern University, Office of Research and Sponsored Programs, Glendale, AZ (AFB); Centre for Drug Research, Universiti Sains Malaysia, 11800 Minden, Penang, Malaysia (DS); Kent School of Social Work, University of Louisville, Louisville, KY (KES); College of Pharmacy, Department of Medicinal Chemistry, University of Florida, FL (OG).
Abstract
OBJECTIVES: To determine whether diagnosed pre-existing health conditions correlate with Kratom demographics and use patterns. METHODS: A cross-sectional, anonymous US national online survey was conducted among 8049 Kratom users in October, 2016 to obtain demographic, health, and Kratom use pattern information. RESULTS: People who use Kratom to mitigate illicit drug dependence self-reported less pain and better overall health than individuals who used Kratom for acute/chronic pain. Self-reported improvements in pre-existing mental health symptoms (attention deficit and hyperactivity disorder/attention deficit disorder, anxiety, bipolar disorder, post-traumatic stress disorder, and depression) attributed to Kratom use were greater than those related to somatic symptoms (back pain, rheumatoid arthritis, acute pain, chronic pain, fibromyalgia). Demographic variables, including female sex, older age, employment status, and insurance coverage correlated with increased likelihood of Kratom use. CONCLUSIONS: Kratom use may serve as a self-treatment strategy for a diverse population of patients with pre-existing health diagnoses. Healthcare providers need to be engaging with patients to address safety concerns and potential limitations of its use in clinical practice for specific health conditions.
OBJECTIVES: To determine whether diagnosed pre-existing health conditions correlate with Kratom demographics and use patterns. METHODS: A cross-sectional, anonymous US national online survey was conducted among 8049 Kratom users in October, 2016 to obtain demographic, health, and Kratom use pattern information. RESULTS: People who use Kratom to mitigate illicit drug dependence self-reported less pain and better overall health than individuals who used Kratom for acute/chronic pain. Self-reported improvements in pre-existing mental health symptoms (attention deficit and hyperactivity disorder/attention deficit disorder, anxiety, bipolar disorder, post-traumatic stress disorder, and depression) attributed to Kratom use were greater than those related to somatic symptoms (back pain, rheumatoid arthritis, acute pain, chronic pain, fibromyalgia). Demographic variables, including female sex, older age, employment status, and insurance coverage correlated with increased likelihood of Kratom use. CONCLUSIONS: Kratom use may serve as a self-treatment strategy for a diverse population of patients with pre-existing health diagnoses. Healthcare providers need to be engaging with patients to address safety concerns and potential limitations of its use in clinical practice for specific health conditions.
Authors: Richard E Harris; David A Williams; Samuel A McLean; Ananda Sen; Michael Hufford; R Michael Gendreau; Richard H Gracely; Daniel J Clauw Journal: Arthritis Rheum Date: 2005-11
Authors: Andrew C Kruegel; Madalee M Gassaway; Abhijeet Kapoor; András Váradi; Susruta Majumdar; Marta Filizola; Jonathan A Javitch; Dalibor Sames Journal: J Am Chem Soc Date: 2016-05-18 Impact factor: 15.419
Authors: W M Shaik Mossadeq; M R Sulaiman; T A Tengku Mohamad; H S Chiong; Z A Zakaria; M L Jabit; M T H Baharuldin; D A Israf Journal: Med Princ Pract Date: 2009-07-31 Impact factor: 1.927
Authors: Kirsten E Smith; Jeffery M Rogers; Justin C Strickland; David H Epstein Journal: Am J Drug Alcohol Abuse Date: 2021-04-28 Impact factor: 3.912
Authors: Lindsay E Johnson; Lilian Balyan; Amy Magdalany; Fizza Saeed; Robert Salinas; Starla Wallace; Charles A Veltri; Marc T Swogger; Zach Walsh; Oliver Grundmann Journal: Yale J Biol Med Date: 2020-06-29
Authors: Antonio Metastasio; Elisabeth Prevete; Darshan Singh; Oliver Grundmann; Walter C Prozialeck; Charles Veltri; Giuseppe Bersani; Ornella Corazza Journal: Front Psychiatry Date: 2020-11-19 Impact factor: 4.157
Authors: Marc T Swogger; Kirsten E Smith; Albert Garcia-Romeu; Oliver Grundmann; Charles A Veltri; Jack E Henningfield; Lorna Y Busch Journal: Front Pharmacol Date: 2022-03-02 Impact factor: 5.810
Authors: Kirsten E Smith; Jeffrey M Rogers; Kelly E Dunn; Oliver Grundmann; Christopher R McCurdy; Destiny Schriefer; David H Epstein Journal: Front Pharmacol Date: 2022-03-01 Impact factor: 5.810
Authors: Elisabeth Prevete; Kim Paula Colette Kuypers; Eef Lien Theunissen; Ornella Corazza; Giuseppe Bersani; Johannes Gerardus Ramaekers Journal: Hum Psychopharmacol Date: 2021-07-26 Impact factor: 2.130